Highfield Resources Ltd
ASX:HFR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Highfield Resources Ltd
ASX:HFR
|
ES |
|
G
|
GP Industries Ltd
SGX:G20
|
SG |
|
Nihon ISK Co Ltd
TSE:7986
|
JP |
|
Neogenomics Inc
NASDAQ:NEO
|
US |
Balance Sheet
Balance Sheet Decomposition
Highfield Resources Ltd
Highfield Resources Ltd
Balance Sheet
Highfield Resources Ltd
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
66
|
55
|
40
|
20
|
22
|
19
|
14
|
12
|
3
|
|
| Cash |
66
|
55
|
40
|
20
|
22
|
19
|
14
|
12
|
3
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
16
|
28
|
39
|
1
|
|
| Total Current Assets |
66
|
56
|
41
|
20
|
22
|
35
|
42
|
51
|
4
|
|
| PP&E Net |
94
|
106
|
117
|
112
|
118
|
131
|
160
|
169
|
162
|
|
| PP&E Gross |
94
|
106
|
117
|
112
|
118
|
131
|
160
|
169
|
162
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
161
N/A
|
162
+1%
|
158
-2%
|
133
-16%
|
141
+6%
|
168
+19%
|
204
+21%
|
221
+8%
|
168
-24%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
2
|
1
|
1
|
3
|
9
|
11
|
12
|
|
| Accrued Liabilities |
2
|
1
|
3
|
3
|
1
|
6
|
8
|
2
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
11
|
10
|
7
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
40
|
46
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
12
|
|
| Total Current Liabilities |
3
|
3
|
5
|
5
|
3
|
20
|
27
|
72
|
76
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
23
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
11
|
4
|
0
|
|
| Total Liabilities |
3
N/A
|
3
-1%
|
5
+101%
|
5
-15%
|
3
-35%
|
20
+585%
|
61
+200%
|
76
+25%
|
76
+0%
|
|
| Equity | ||||||||||
| Common Stock |
172
|
173
|
173
|
173
|
190
|
204
|
207
|
223
|
231
|
|
| Retained Earnings |
17
|
20
|
25
|
48
|
54
|
59
|
71
|
90
|
160
|
|
| Other Equity |
3
|
7
|
6
|
4
|
2
|
3
|
8
|
12
|
21
|
|
| Total Equity |
158
N/A
|
159
+1%
|
153
-4%
|
129
-16%
|
139
+8%
|
148
+7%
|
143
-3%
|
145
+1%
|
92
-37%
|
|
| Total Liabilities & Equity |
161
N/A
|
162
+1%
|
158
-2%
|
133
-16%
|
141
+6%
|
168
+19%
|
204
+21%
|
221
+8%
|
168
-24%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
329
|
330
|
330
|
330
|
364
|
387
|
392
|
449
|
474
|
|